Vasogen Incorporated

R&D for the treatment of vascular diseases. VasoCare has demonstrated effectiveness for the treatment of peripheral occlusive cardiovascular disease.

Contact Details: 2155 Dunwin Drive, Suite 10 Mississauga Ontario L5L4M1 Canada Tel: 905 569 2265 Fax: 905 569 9231 Email: WWW: www.vasogen.com/

Loading...

Recent Publications by Vasogen Incorporated:
A novel phospholipid-based drug formulation, VP025, modulates age- and LPS-induced microglial activity in the rat. BACKGROUND: A common change that occurs with age in the central nervous...	18th July, 2009	Vasogen Ireland Ltd., Trinity College Institute of Neuroscience,	Neuroimmunomodulation. 2009;16(6):400-10. Epub 2009 Jul 17. DOI Direct Link
Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's disease. Failure of the ubiquitin-proteasome system to degrade abnormal proteins...	13th January, 2009	Vasogen Ireland Ltd., Dublin, Ireland; Department of Anatomy and	Behav Brain Res. 2008 Dec 22;195(2):271-4. Epub 2008 Sep 4. DOI Direct Link
Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease. Administration of VP025 (Vasogen Inc.), a novel drug formulation based on...	9th April, 2008	Vasogen Ireland Ltd, Dublin, Ireland.	Eur J Neurosci. 2008 Jan;27(2):294-300. Epub 2008 Jan 11. DOI Direct Link
Biologic effects and basic science of a novel immune-modulation therapy. The immune system is a system of dynamic equilibrium, with inflammatory...	20th July, 2005	Vasogen Ireland	Am J Cardiol. 2005 Jun 6;95(11A):24C-29C; discussion 38C-40C. DOI Direct Link

BioNews Results for Vasogen Incorporated:
Intellipharmaceutics and Vasogen Inc. Complete Arrangement to Create Publicly-traded Specialty Pharmaceutical	Pharma Live:  Oct 25 2009 5:08PM Matching: vasogen
Intellipharmaceutics and Vasogen Inc. Complete Arrangement to Create Publicly-traded Specialty Pharmaceutical	TickerTech.com:  Oct 23 2009 4:34PM Matching: vasogen
Vasogen completes merger with IntelliPharmaCeutics	Individual.com:  Oct 23 2009 6:24PM Matching: vasogen
Intellipharmaceutics and Vasogen Inc. Complete Arrangement to Create Publicly-traded Specialty Pharmaceutical	CNW Telbec:  Oct 22 2009 10:48PM Matching: vasogen
Intellipharmaceutics and Vasogen Inc. Complete Arrangement to Create Publicly-traded Specialty Pharmaceutical Company	CNW Telbec:  Oct 22 2009 2:54PM Matching: vasogen
Promote your company here: BioNewsCast - Press Release Distribution	→View more Vasogen Incorporated news.

Vasogen Incorporated Clinical Trials:
SIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease and Intermittent Claudication Outcomes

Vasogen Incorporated Patents:
US Patent No.	Title
7597906	Apoptosis-mimicking synthetic entities and use thereof in medical treatment
6733748	Chronic lymphocytic leukemia treatment
6719715	Apparatus and process for conditioning organic fluid
6696092	Endothelial lining effects and treatment of vasospastic disorders
6669965	Method of treating atherosclerosis
→View more Vasogen Incorporated patents.

Vasogen Incorporated (VSGN) Financial information Links from Barchart
VSGN Quote from from Barchart.com
VSGN Chart from from Barchart.com
VSGN Profile from from Barchart.com
VSGN Opinion from from Barchart.com
→View more Vasogen Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 359 times since April 2007, the link to the organisation's website has been followed 56 times

Search for more companies in Mississauga

Search for more companies in Ontario

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Vasogen Incorporated